Shanghai Fosun Pharmaceutical (Group) Co., Ltd. disclosed that, for the month ended 31 October 2025, the total authorized share capital remained at RMB 2,670,429,325. The H shares (stock code: 02196) account for 551,940,500 shares, while the A shares (stock code: 600196) stand at 2,118,488,825 shares, both with a par value of RMB 1 per share.

According to the report, the numbers of issued shares and treasury shares under both the H share and A share categories did not change compared to the previous month. The H shares continue to have 540,971,500 issued shares and 10,969,000 treasury shares, whereas the A shares maintain 2,098,582,573 issued shares and 19,906,252 treasury shares.

No movements were reported in relation to share options, warrants, convertibles, or other agreements to issue shares. The announcement confirms full compliance with applicable regulations and listing rules for the reporting period.